Clinical Trial Update: Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating the safety and feasibility of discontinuing imatinib in adults with chronic myeloid leukemia who have ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Chronic Myeloid Leukemia, Imatinib | NA | Status: UNKNOWN